​Should you buy, sell or hold Crompton Greaves Consumer Electricals, Godrej Consumer, Nykaa, Sun Pharma other stocks in focus today?

Which stocks to buy, hold or sell today? As Dalal Street enters the March 27 session — here's a look at what brokerages make of some of the key stocks in focus. Stocks like Crompton Greaves, Godrej Consumer, Nykaa, Sun Pharma, Phoenix Mills, and others are on their radar.

Do you have any of these stocks in your portfolio?

Check out the full list of brokerage calls on Crompton Greaves, Godrej Consumer, Nykaa, Sun Pharma, Phoenix Mills:

Crompton Greaves

Global brokerages CLSA and Nomura are upbeat on Crompton Greaves Consumer Electricals after the company announced a merger with kitchen appliances firm Butterfly Gandhimathi.

CLSA maintained an ‘outperform’ rating with a target price of Rs 350 per share. The brokerage said a large part of synergy will have accrued under the current structure; it added the merger could help in realisation of synergy and improve market share.

Similarly, Nomura maintained a ‘buy’ rating on the stock with a target of Rs 377 per share. It said that the company expects the proposed merger to be EPS accretive from the first year.

Godrej Consumer Products

Jefferies maintained a ‘buy’ stance on Godrej Consumer Products and raised the target price to Rs 1,200 from 1,090 per share. According to brokerage, initiatives on access packs are yielding results, especially in hair colors, besides, category development efforts are seeing good response.

Jefferies on Life Insurers

Jefferies is bullish on life insurance companies such as SBI Life Insurance. HDFC Life Insurance, ICICI Prudential Life Insurance, and Max Financial Services. It has a ‘buy’ rating on all four life insurance companies’ shares, however, slashed targets.

Phoenix Mills

Morgan Stanley initiated an ‘overweight’ rating on Phoenix Mills with a target of Rs 1,700 a share. The brokerage said the company has a portfolio of well-located, mixed-use destination malls, and it is set to benefit from India's consumption growth.

Moreover, the company is in the expansion phase and aims to more than double its rental portfolio over the next 3-4 years, Morgan Stanley further said in its note on Phoenix Mills.

Nykaa

Morgan Stanley has an ‘overweight’ rating on Nykaa with a target of Rs 206 apiece, while Jefferies retained a ‘buy’ call on the stock with a target of Rs 200 per share.

Sun Pharma

Credit Suisse upgraded Sun Pharma to ‘outperform’ from a ‘neutral’ rating with a raised target of Rs 1,150 per share from Rs 950 apiece earlier.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.